Works by Nong Yang


Results: 63
    1
    2
    3
    4
    5

    Postoperative intensity‐modulated radiation therapy reduces local recurrence and improves overall survival in III‐N2 non‐small‐cell lung cancer: A single‐center, retrospective study.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 8, p. 2820, doi. 10.1002/cam4.2937
    By:
    • Wei, Wei;
    • Zhou, Jiao;
    • Zhang, Qun;
    • Liao, De‐Hua;
    • Liu, Qiao‐Dan;
    • Zhong, Bei‐Long;
    • Liang, Zi‐Bin;
    • Zhang, Yong‐Chang;
    • Jiang, Rong;
    • Liu, Gui‐Yun;
    • Xu, Chen‐Yang;
    • Li Zhou, Huai‐;
    • Zhu, Su‐Yu;
    • Yang, Nong;
    • Jiang, Wen;
    • Liu, Zhi‐Gang
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Chinese Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (5A) Registry protocol: rationale, design and methodology.

    Published in:
    BMC Cardiovascular Disorders, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12872-024-03760-y
    By:
    • Liu, Hong;
    • Qian, Si-chong;
    • Li, Hai-yang;
    • Shao, Yong-feng;
    • Zhang, Hong-jia;
    • the China Additive Anti-inflammatory Action for Aortopathy, Arteriopathy (5A) Investigators;
    • Han, Lu;
    • Zhang, Ying-yuan;
    • Wang, Kai;
    • Wu, Ying;
    • Hong, Liang;
    • Yang, Ji-nong;
    • Zhong, Ji-sheng;
    • Sun, Bing-qi;
    • Liu, Xiao-cheng;
    • Wu, Dong-kai;
    • Fan, Guo-liang;
    • Chen, Jun-quan;
    • Zhang, Sheng-qiang;
    • Jiang, Yi-yao
    Publication type:
    Article
    19
    20
    21

    Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Advanced Non–Small Cell Lung Cancer After Second-Line Treatment Failure: A Nonrandomized Clinical Trial.

    Published in:
    JAMA Network Open, 2020, v. 3, n. 3, p. e201226, doi. 10.1001/jamanetworkopen.2020.1226
    By:
    • Zhang, Xiangyu;
    • Xiong, Yi;
    • Xia, Qing;
    • Wu, Fang;
    • Liu, Lingli;
    • Zhou, Yuling;
    • Zeng, Liang;
    • Zhou, Chunhua;
    • Xia, Chen;
    • Jiang, Wenjuan;
    • Liao, Dehua;
    • Xiao, Lili;
    • Liu, Li;
    • Yang, Haiyan;
    • Guan, Rui;
    • Li, Kunyan;
    • Wang, Jing;
    • Lei, Guang;
    • Zhang, Yongchang;
    • Yang, Nong
    Publication type:
    Article
    22

    Polymorphisms of Drug-Metabolizing Enzymes and Transporters Contribute to the Individual Variations of Erlotinib Steady State Trough Concentration, Treatment Outcomes, and Adverse Reactions in Epidermal Growth Factor Receptor–Mutated Non-Small Cell Lung Cancer Patients

    Published in:
    Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00664
    By:
    • Liao, Dehua;
    • Liu, Zhigang;
    • Zhang, Yongchang;
    • Liu, Ni;
    • Yao, Dunwu;
    • Cao, Lizhi;
    • Chen, Yun;
    • Fu, Yilan;
    • Yang, Nong;
    • Xiang, Daxiong
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30

    A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancer.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 2, p. 477, doi. 10.1007/s10637-020-01010-4
    By:
    • Yang, Jin-Ji;
    • Fang, Jian;
    • Shu, Yong-Qian;
    • Chang, Jian-Hua;
    • Chen, Gong-Yan;
    • He, Jian Xing;
    • Li, Wei;
    • Liu, Xiao-Qing;
    • Yang, Nong;
    • Zhou, Caicun;
    • Huang, Jian An;
    • Frigault, Melanie M.;
    • Hartmaier, Ryan;
    • Ahmed, Ghada F.;
    • Egile, Coumaran;
    • Morgan, Shethah;
    • Verheijen, Remy B.;
    • Mellemgaard, Anders;
    • Yang, Liu;
    • Wu, Yi-Long
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37

    Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB–III non‐small cell lung cancer patients using radiomic features.

    Published in:
    Thoracic Cancer, 2023, v. 14, n. 28, p. 2869, doi. 10.1111/1759-7714.15052
    By:
    • Yang, Nong;
    • Yue, Hai‐Lin;
    • Zhang, Bai‐Hua;
    • Chen, Juan;
    • Chu, Qian;
    • Wang, Jian‐Xin;
    • Yu, Xiao‐Ping;
    • Jian, Lian;
    • Bin, Ya‐Wen;
    • Liu, Si‐Ye;
    • Liu, Jin;
    • Zeng, Liang;
    • Yang, Hai‐Yan;
    • Zhou, Chun‐Hua;
    • Jiang, Wen‐Juan;
    • Liu, Li;
    • Zhang, Yong‐Chang;
    • Xiong, Yi;
    • Wang, Zhan
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study

    Published in:
    Cancer Communications, 2022, v. 42, n. 1, p. 3, doi. 10.1002/cac2.12225
    By:
    • Zhang, Jie;
    • Pan, Yueyin;
    • Shi, Qin;
    • Zhang, Guojun;
    • Jiang, Liyan;
    • Dong, Xiaorong;
    • Gu, Kangsheng;
    • Wang, Huijuan;
    • Zhang, Xiaochun;
    • Yang, Nong;
    • Li, Yuping;
    • Xiong, Jianping;
    • Yi, Tienan;
    • Peng, Min;
    • Song, Yong;
    • Fan, Yun;
    • Cui, Jiuwei;
    • Chen, Gongyan;
    • Tan, Wei;
    • Zang, Aimin
    Publication type:
    Article
    47
    48
    49
    50